All Stories

  1. Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes

    Article • Expert Opinion on Pharmacotherapy, November 2018, Taylor & Francis

    Dr. Kashif M Munir, Paul Solinsky